Table: Rohto -2019/20 parent results
May 12 (Reuters)-
Rohto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2020 Mar 31, 2019 Mar 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 106.48 104.38
(+2.0 pct) (+7.7 pct)
Operating 13.26 13.01
(+1.9 pct) (+1.2 pct)
Recurring 14.37 15.19
(-5.4 pct) (+2.3 pct)
Net 6.98 4.82
(+44.9 pct) (-36.9 pct)
EPS 61.19 yen 42.26 yen
EPS Diluted 61.00 yen 42.10 yen
Ann Div 26.00 yen 25.00 yen 27.00 yen
-Q2 Div 13.00 yen 11.00 yen 13.00 yen
-Q4 Div 13.00 yen 14.00 yen 14.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T